重庆智飞生物稳健经营,发展迈向新高度-堆叠折线图-数据可视化

智飞生物(300122),全称重庆智飞生物制品股份有限公司(Chongqing Zhifei Biological Products Co., Ltd.),主营业务为疫苗、生物制品的研发、生产和销售。,位于重庆重庆市,董事长为蒋仁生,总经理为蒋仁生。网址为www.zhifeishengwu.com。

《重庆智飞生物稳健经营,发展迈向新高度》重庆智飞生物制品股份有限公司(Chongqing Zhifei Biological Products Co., Ltd.)是一家专注于疫苗、生物制品研发、生产和销售的国家级高新技术企业,位于重庆重庆市,由蒋仁生先生担任董事长及总经理,从他们的财务报表可以窥见到企业的发展情况。自2012年至2022年,公司的非流动资产合计在不断增长,增长幅度从7年前的644.7亿元增长至现在的6590.4亿元。可见,重庆智飞在这十几年的稳健经营下,越办越大,发展迈向新高度。重庆智飞成立以来依托先进的科技和自身技术实力,完善管理模式,积极响应国家发展方向,以质量求生存、以服务求发展、以创新求持续发展等理念,发挥了科技在疫苗领域中应有的市场推动作用,在行业中继续占据着很重要的地位。今天,重庆智飞已成为中国医疗健康领域最重要的现实力量之一,取得了显著的成绩。未来,重庆智飞将根据行业蓝图,积极参与推进“解决慢性病的全球健康解决方案”的制定,以及“专业的生物医药产品生态系统”的构建,以准确预报抗疫事态的发展,为患者提供有效的治疗途径,助力社会健康发展。通过多年来积极投资研发,强化服务质量,

Description:重庆智飞生物制品股份有限公司(300122)是专注于研发和生产疫苗和生物制品的研发、生产和销售的高科技制药公司。,"300122","智飞生物","Zhifei Biological","蒋仁生","蒋仁生","ESG 300","创业板50","创业板指","创业新兴","分析师指数","国证A50","国证A指","沪深300","巨潮100","巨潮大盘","深成指R","深证100","深证100R","深证300","深证成指","深证新兴","深证责任","中创100","中证100","中证新兴","数据可视化","上市公司财报","数据分析","堆叠折线图","花火数图","图表"

我也要免费做堆叠折线图

Description:重庆智飞生物制品股份有限公司(300122)是专注于研发和生产疫苗和生物制品的研发、生产和销售的高科技制药公司。,"300122","智飞生物","Zhifei Biological","蒋仁生","蒋仁生","ESG 300","创业板50","创业板指","创业新兴","分析师指数","国证A50","国证A指","沪深300","巨潮100","巨潮大盘","深成指R","深证100","深证100R","深证300","深证成指","深证新兴","深证责任","中创100","中证100","中证新兴","数据可视化","上市公司财报","数据分析","堆叠折线图","花火数图","图表"

我也要免费做堆叠折线图

报表日期非流动资产合计
202212316,590,371,385.25
202112315,293,543,061.19
202012313,678,246,246.08
201912312,775,901,293.97
201812312,193,703,915.81
201712311,820,167,117.07
201612311,571,250,771.37
201512311,322,252,444.93
201412311,094,826,969.27
20131231836,155,357.47
20121231644,723,205.26
20111231442,732,850.11
20101231199,042,163.28
20091231170,262,191.53
20081231135,334,189.57
2007123146,248,383.22

我也要免费做堆叠折线图